Who Owns Immunocore Stock?
NASDAQ: IMCRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 103.41%
- Institutions (% of float)
- 103.48%
- Held by insiders
- 0.07%
- Institutional holders
- 174
- Institutions 99.9%
- Insiders 0.1%
- Public and other 0.0%
Who owns Immunocore stock?
Institutional investors own about 103.4% of Immunocore's shares, spread across 174 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.07% of IMCR.
The largest institutional holders are Wellington Management Group, LLP (11.06%), RTW Investments LP (9.42%) and Primecap Management Company (7.04%). Together, the top 10 institutions control 54.6% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their IMCR positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of IMCR
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Wellington Management Group, LLP | 5.72M | 11.06% | -0.1% |
| RTW Investments LP | 4.87M | 9.42% | 0.0% |
| Primecap Management Company | 3.64M | 7.04% | -0.1% |
| Tang Capital Management, LLC | 2.88M | 5.58% | +8.9% |
| Bellevue Group AG | 2.26M | 4.38% | -18.8% |
| Two Sigma Investments, LP | 2.02M | 3.90% | +22.2% |
| Acadian Asset Management. LLC | 1.82M | 3.53% | +50.8% |
| FMR, LLC | 1.74M | 3.36% | -59.7% |
| Caligan Partners, LP | 1.67M | 3.24% | +21.1% |
| Millennium Management Llc | 1.60M | 3.09% | +29.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of IMCR
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 4.25M | 8.22% |
| VANGUARD HORIZON FUNDS-Vanguard Capital Opportunity Fund | 2.34M | 4.52% |
| PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund | 1.11M | 2.15% |
| T. Rowe Price Health Sciences Fund, Inc. | 645.27K | 1.25% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 500.00K | 0.97% |
| BlackRock Health Sciences Term Trust | 359.13K | 0.69% |
| iShares Trust-iShares Biotechnology ETF | 353.56K | 0.68% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 324.82K | 0.63% |
| MFS SERIES TRUST I-MFS New Discovery Fund | 304.30K | 0.59% |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | 260.00K | 0.50% |
Frequently asked questions
Who is the largest shareholder of Immunocore?
Wellington Management Group, LLP is the largest institutional shareholder of IMCR, owning 11.06% of shares outstanding (5.72M shares) as of its latest 13F filing.
What percentage of Immunocore is owned by institutions?
Institutions own about 103.4% of IMCR shares and 103.5% of the public float.
How much of Immunocore do insiders own?
Insiders, such as officers and directors, own about 0.07% of IMCR shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.